107 related articles for article (PubMed ID: 8384185)
1. Clinical aspects of ephedrine in the treatment of obesity.
Pasquali R; Casimirri F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S65-8. PubMed ID: 8384185
[No Abstract] [Full Text] [Related]
2. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
3. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Toubro S; Astrup A; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Toubro S; Astrup AV; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
[TBL] [Abstract][Full Text] [Related]
6. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann B; Marckmann P; Christensen NJ; Astrup A
Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
[TBL] [Abstract][Full Text] [Related]
7. Herbal simulation of ephedrine and caffeine in treatment of obesity.
Dulloo AG
Int J Obes Relat Metab Disord; 2002 May; 26(5):590-2. PubMed ID: 12032740
[No Abstract] [Full Text] [Related]
8. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Molnár D; Török K; Erhardt E; Jeges S
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
[TBL] [Abstract][Full Text] [Related]
9. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Daly PA; Krieger DR; Dulloo AG; Young JB; Landsberg L
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
[TBL] [Abstract][Full Text] [Related]
10. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial using ephedrine in the treatment of obesity.
Miller DS
Int J Obes; 1986; 10(2):159-60. PubMed ID: 3522451
[No Abstract] [Full Text] [Related]
12. Pharmacology of thermogenic drugs.
Astrup A; Toubro S; Christensen NJ; Quaade F
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
[TBL] [Abstract][Full Text] [Related]
13. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Astrup A; Lundsgaard C
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
[TBL] [Abstract][Full Text] [Related]
14. [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].
Quaade F; Astrup A; Breum L; Toubro S; Hein P
Ugeskr Laeger; 1992 Apr; 154(18):1258-63. PubMed ID: 1598695
[No Abstract] [Full Text] [Related]
15. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
[TBL] [Abstract][Full Text] [Related]
16. Responses of brown adipose tissue to diet-induced obesity, exercise, dietary restriction and ephedrine treatment.
Slocum N; Durrant JR; Bailey D; Yoon L; Jordan H; Barton J; Brown RH; Clifton L; Milliken T; Harrington W; Kimbrough C; Faber CA; Cariello N; Elangbam CS
Exp Toxicol Pathol; 2013 Jul; 65(5):549-57. PubMed ID: 22542811
[TBL] [Abstract][Full Text] [Related]
17. Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
Krieger DR; Daly PA; Dulloo AG; Ransil BJ; Young JB; Landsberg L
Trans Assoc Am Physicians; 1990; 103():307-12. PubMed ID: 2132541
[No Abstract] [Full Text] [Related]
18. Ephedrine, a thermogenic and potential slimming drug.
Massoudi M; Miller DS
Proc Nutr Soc; 1977 Dec; 36(3):135A. PubMed ID: 601014
[No Abstract] [Full Text] [Related]
19. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
[No Abstract] [Full Text] [Related]
20. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man.
Astrup A; Toubro S
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S41-3. PubMed ID: 8384179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
